β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 101 β 17 SEPTEMBER 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Gliolan
Aminolevulinic acid hydrochloride 1.5g
Powder for oral solution
Specialised Therapeutics Limited
IDT Biologika GmbH, Dessau Rosslau, Germany
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Inflectra
Infliximab 100mg
Powder for injection
Pharmbio Pty Limited
Mustafa Nevzat Ilac Sanayii A.S., Istanbul, Turkey
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Kevtam
Levetiracetam 250mg
Film coated tablet
Mylan New Zealand Limited
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Kevtam
Levetiracetam 500mg
Film coated tablet
Mylan New Zealand Limited
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Kevtam
Levetiracetam 750mg
Film coated tablet
Mylan New Zealand Limited
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Kevtam
Levetiracetam 1000mg
Film coated tablet
Mylan New Zealand Limited
Mylan Pharmaceuticals Inc, West Virginia, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Remsima
Infliximab 100mg
Powder for injection
Pharmbio Pty Limited
Mustafa Nevzat Ilac Sanayii A.S., Istanbul, Turkey
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Tramadol Actavis
Tramadol hydrochloride 50mg/mL
Solution for injection
Actavis New Zealand Limited
Laboratorios Norman SA, Madrid, Spain
Dated this 11th day of September 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go5473
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
54
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare11 September 2015
Medicines, Distribution, Medicines Act 1981, New Medicines
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 101